Skip to content

Magnetic Resonance flow measurements of mesenteric arteries and veins and portal vein with food stimulation and mitochondrial oxygen measurements during routine upper endoscopy in patients suspected of chronic gastro-intestinal ischemia

Magnetic Resonance flow measurements of mesenteric arteries and veins and portal vein with food stimulation and mitochondrial oxygen measurements during routine upper endoscopy in patients suspected of chronic gastro-intestinal ischemia - MR flow MitoO2 study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON55671
Enrollment
62
Registered
2016-02-17
Start date
2017-02-14
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic gastro-intestinal ischemia

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients suspected of CGI referred to our hospital for further analysis 2. Age >= 18 years 3. Patients who gave informed consent

Exclusion criteria

Exclusion criteria: 1. Age 2 times upper limit of normal

Design outcomes

Primary

MeasureTime frame
- To determine the difference in baseline MR flow measurements and post prandial MR flow measurements between patients diagnosed with CGI and patients not diagnosed with CGI - To gather information on the potential of endoscopic mitochondrial oxygen measurements in diagnosing CGI in patients suspected of CGI.

Secondary

MeasureTime frame
- To determine which vessel or which combination of vessels best differentiates between patients diagnosed with CGI and patients not diagnosed with CGI by MR flow measurement - The severity of abdominal pain in course of time after stimulation with nutritional drink, using the Numeric Pain Intensity scale at baseline and 20, 30 and 40 minutes after nutritional drink. - To determine the difference in MR flow measurements of the mesenteric vessels prior to and after treatment in patients diagnosed with CGI with persistent relief of symptoms after treatment.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)